Immunotherapy

Prescient Therapeutics Investor Briefing – 21 January

January 21, 2021

Australian clinical stage biotech company Prescient Therapeutics (ASX: PTX) will undertake three internal development programs to advance its

January 20, 2021 0 Comments

November 12, 2020

Prescient Therapeutics (ASX:PTX) are focused on developing novel, personalised therapies for a range of cancers through universal CAR-T

November 4, 2020

In the battle against blood cancer, chimeric antigen receptor T cell (CAR-T) therapy is proving to be a

November 4, 2020 0 Comments

September 10, 2020

Australian listed biotechnology company Prescient Therapeutics (ASX: PTX) today updated the market on progress on one of its

August 19, 2020 0 Comments

August 14, 2020

Australian listed biotechnology company Prescient Therapeutics (ASX: PTX) today updated the market on progress on one of its

August 12, 2020 0 Comments

Every year 45,000 of the most respected professionals in oncology gather at the American Society of Clinical Oncology

August 5, 2020 0 Comments